FDA-Inspected Site

Mani, Inc. - Kiyohara Facility

3 FDA inspections are on record for Mani, Inc. - Kiyohara Facility in Utsunomiya, Japan.

Clean· No action indicated

Utsunomiya, Japan · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2018-07-11.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Jul 2018 – 11 Jul 2018Medical Devices & Rad HealthClean
20 May 2013 – 23 May 2013Medical Devices & Rad Health483View 483 →
7 Oct 2010Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 May 2013
21 CFR 820.30(c)

Design input - Lack of or inadequate procedures

Cited by Eric M Padgett

23 May 2013
21 CFR 820.100(b)

Documentation

Cited by Eric M Padgett

23 May 2013
21 CFR 820.198(a)

Complaints

Cited by Eric M Padgett

7 Oct 2010
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Frank J Marciniak

7 Oct 2010
21 CFR 820.25(b)

Training records

Cited by Frank J Marciniak

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(b)Cited across public-safe Form 483 observations2x
21 CFR 820.198(a)Cited across public-safe Form 483 observations2x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(c)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Mani, Inc. - Kiyohara Facility's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat